Skip to main content

Enrollment in the Health Benefits for Immigrant Adults (HBIA) program will be temporarily paused effective July 1, 2023.

Enrollment in the Health Benefits for Immigrant Seniors (HBIS) program will be temporarily paused effective Nov. 6, 2023.

Elizabeth M. Whitehorn, Director

Drugs and Therapeutics (D & T) Committee Meeting Results for: March 24, 2010

Drug Name Review Type Committee Recommendation Prior Approval Status � Final Determination
Bepreve New Drug Initial Review Require Prior Approval Prior Approval Required
Vivitrol New Drug Initial Review Require Prior Approval Prior Approval Required
Colcrys New Drug Initial Review Require Prior Approval Prior Approval Required
Sabril New Drug Initial Review Require Prior Approval Prior Approval Required
Twynsta New Drug Initial Review Require Prior Approval Prior Approval Required
Apriso New Drug Initial Review Remove Prior Approval Requirement Prior Approval Requirement Removed
Besivance New Drug Appeal Require Prior Approval Prior Approval Required
Ranexa New Drug Appeal Require Prior Approval Prior Approval Required
Vimpat New Drug Appeal Remove Prior Approval Requirement Prior Approval Required
Lamictal XR New Drug Appeal Removed from Agenda Prior to Mtg Prior Approval Required
Ulesfia New Drug Appeal Remove Prior Approval Requirement Prior Approval Required
Zenpep New Drug Appeal Remove Prior Approval Requirement Prior Approval Requirement Removed
Xibrom PDL Appeal Require Prior Approval Prior Approval Required
Istalol PDL Appeal Require Prior Approval Prior Approval Required